Profile for Denmark Patent: 2187742
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Denmark Patent: 2187742
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 7,838,499 | Jan 30, 2029 | Theracosbio | BRENZAVVY | bexagliflozin |
| 8,106,021 | Aug 22, 2028 | Theracosbio | BRENZAVVY | bexagliflozin |
| 8,802,637 | Aug 22, 2028 | Theracosbio | BRENZAVVY | bexagliflozin |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
